cyclo(tyrosyl-tyrosyl) has been researched along with clotrimazole in 2 studies
*Clotrimazole: An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [MeSH]
*Clotrimazole: An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [MeSH]
| Studies (cyclo(tyrosyl-tyrosyl)) | Trials (cyclo(tyrosyl-tyrosyl)) | Recent Studies (post-2010) (cyclo(tyrosyl-tyrosyl)) | Studies (clotrimazole) | Trials (clotrimazole) | Recent Studies (post-2010) (clotrimazole) |
|---|---|---|---|---|---|
| 8 | 0 | 7 | 2,005 | 299 | 503 |
| 7 | 0 | 4 | 2,005 | 299 | 503 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Carvalho, LPS; Gomaa, MS; Helal, MA; Kishk, SM; McLean, KJ; Mostafa, SM; Munro, AW; Salama, I; Simons, C; Sood, S | 1 |
| Abell, C; Blankley, RT; Campbell, B; Charoensutthivarakul, S; Coyne, AG; de Carvalho, LPS; Evangelopoulos, D; Frederickson, M; Katariya, MM; Kavanagh, ME; Levy, CW; Leys, D; McLean, KJ; Munro, AW; Selvam, IR; Tunnicliffe, RB | 1 |
2 other study(ies) available for cyclo(tyrosyl-tyrosyl) and clotrimazole
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
Topics: Antitubercular Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipeptides; Drug Design; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Peptides, Cyclic; Piperazines; Tuberculosis | 2019 |
A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).
Topics: Antitubercular Agents; Drug Design; Humans; Mycobacterium tuberculosis; Tuberculosis; X-Rays | 2022 |